| Oct 8 |
Scholar Rock stocks skyrocket after SMA drug scores at Phase III
|
| Oct 7 |
Scholar Rock: SMA Program Strides Forward With Positive Clinical Data
|
| Oct 7 |
Scholar Rock announces proposed public offering of common stock, pre-funded warrants
|
| Oct 7 |
Scholar Rock Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
|
| Oct 7 |
Scholar Rock surges 335% on phase 3 spinal muscular atrophy candidate data
|
| Oct 7 |
How Is The Market Feeling About Scholar Rock Holding?
|
| Oct 7 |
Top Midday Gainers
|
| Oct 7 |
Scholar Rock Shares Quadruple On Positive Drug-Study Results
|
| Oct 7 |
Scholar Rock stock surges on positive spinal muscular atrophy treatment data
|
| Oct 7 |
Scholar Rock Stock Quadruples on Positive Trial Data
|
